Literature DB >> 22473540

ONe More Weapon in the FIght Against Drop Seizures in Lennox-Gastaut Syndrome.

Eric Kossoff.   

Abstract

Entities:  

Year:  2012        PMID： 22473540      PMCID： PMC3316357          DOI： 10.5698/1535-7511-12.2.53

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  6 in total

1.  Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome.

Authors:  Y T Ng; J A Conry; R Drummond; J Stolle; M A Weinberg
Journal:  Neurology       Date:  2011-09-28       Impact factor: 9.910

Review 2.  Clobazam.

Authors:  Yu-tze Ng; Stephen D Collins
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

3.  Vigabatrin for the treatment of infantile spasms: final report of a randomized trial.

Authors:  Roy D Elterman; W Donald Shields; Richard M Bittman; Sarah A Torri; Stephen M Sagar; Stephen D Collins
Journal:  J Child Neurol       Date:  2010-04-19       Impact factor: 1.987

Review 4.  New and forthcoming anti-epileptic drugs.

Authors:  Paolo Prunetti; Emilio Perucca
Journal:  Curr Opin Neurol       Date:  2011-04       Impact factor: 5.710

5.  Clobazam in the treatment of Lennox-Gastaut syndrome.

Authors:  Joan A Conry; Yu-Tze Ng; Juliann M Paolicchi; Lydia Kernitsky; Wendy G Mitchell; Frank J Ritter; Stephen D Collins; Katherine Tracy; William N Kormany; Radhi Abdulnabi; Bill Riley; Julie Stolle
Journal:  Epilepsia       Date:  2008-12-15       Impact factor: 5.864

6.  Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome.

Authors:  T Glauser; G Kluger; R Sachdeo; G Krauss; C Perdomo; S Arroyo
Journal:  Neurology       Date:  2008-04-09       Impact factor: 9.910
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.